It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
The Biden administration is facing mounting pressure from states to let them import medicine from Canada to help lower prescription drug costs.
Colorado on Dec. 5 became at least the fourth state to seek federal permission to use the strategy, following Florida, New Hampshire, and New Mexico. President Biden has endorsed the approach, but his administration has yet to greenlight a state plan.
Stall tactics?
Americans pay among the highest prices in the world for brand-name pharmaceuticals. Drugs are generally less expensive in neighboring Canada, where the government controls prices.
Under former President Donald Trump, the U.S. government declared that importing drugs from Canada could be done safely — satisfying a condition spelled out in a 2003 federal drug importation law. The Trump administration finalized rules in September 2020 for states to apply.
During his campaign for the White House, Mr. Biden said he would allow consumers to import prescription drugs from other countries if the federal government certified those drugs as safe.
After Mr. Biden took office in 2021, he ordered the FDA to work with states to import prescription drugs from Canada. In a speech last year about how he was going to reduce drug prices, he cited estimates by Colorado about how much money people in the state could save through importation.
Despite the administration's public show of support, early applicants have been frustrated by the FDA's inaction.
In August, almost two years after submitting its drug proposal, Florida sued the federal government, accusing the Biden administration of slow-walking its review. The federal government denied the accusation. Florida Gov. Ron DeSantis, a potential Republican presidential contender for 2024, has championed the state's effort.
In November, about three months after Florida sued, the FDA sent Florida a 15-page letter asking it to fill dozens of gaps in its plan. The letter asked whether the state wanted to withdraw its application and submit another.
In a December court filing, Florida said "suddenly conjuring so many supposed defects" in its proposal was another "stall tactic" by the government.
New Hampshire Health and Human Services Department spokesperson Jake Leon said New Hampshire's proposal was rejected because it did not identify a Canadian wholesaler that would provide the drugs. He said the FDA told the state it could reapply when it found one.
The Colorado Business Group on Health, which includes large employers, strongly favors importation but realizes the Biden administration is under pressure from groups that profit from the status quo, said Robert Smith, the coalition's executive director. He called concerns about patient safety a "red herring."
"The one thing we know about health care is that it is driven by economic self-interests," he said.
originally posted by: Hypntick
a reply to: putnam6
I've been wondering this myself for a while now. I'm asthmatic, and it is around $70 for an inhaler without insurance here, yet when I went overseas, it was over the counter and $12. I stocked up on about a dozen of them at the time. If this were the norm here, it would make things significantly easier for everyone. However, I don't see it happening; someone has to foot the R&D bill for the pharma corps; we're, unfortunately, the country that has to bear that burden.
Most of Pharma’s drugs aren't even life-saving—a lot more thyroid, cholesterol, ADHD and acid reflux drugs are sold than cancer drugs, their demand whipped up by direct-to-consumer drug ads. (Some widely marketed drugs like statins and acid reflux meds have life-threatening side effects of their own.) PhRMA’s “Hope to Cures” campaign even claims high-priced meds help the economy by creating jobs, like for “sheet metal workers.” Right.
Parading sick patients in front of the FDA and state officials who decide drug reimbursements is how Pharma has gotten drugs that cost four, five and six digits approved, usually paid for by taxpayers. Co-opted patients (sometimes called Astroturf because they are not really grassroots) “appear before public and consumer panels, contact lawmakers, and provide media outlets a human face to attach to a cause,” writes Melissa Healy of the Los Angeles Times, “when insurers balk at reimbursing patients for new prescription medications.”
Nowhere in the PhRMA PR campaign are actual costs mentioned like the 12 cancer drugs that cost above $100,000 a year though many do not clearly even extend life. A year on a cocktail of psychiatric drugs can easily cost $60,000. Instead we hear about rare diseases and rare cancers that presumably would not be cured if lawmakers curtail Big Pharma profits.
originally posted by: putnam6
Mentioned this in a thread 2 years ago if not more about Truliticy and it was $750 a month, searching around I got 3 months' worth for 10 times less but you had to search around and ask questions. It's a big-time hassle and you could only do this once with this pharmacy, but obviously big Pharma knows enough people will accept the price because it goes on thier damn insurance. My sister was on the exact same prescription as my Mom I got Mom's for 79 dollars my sister paid $349 same milligrams for 30 days
So why can't they give some of us Boomers a tad bit of relief?
www.cbsnews.com...
The Biden administration is facing mounting pressure from states to let them import medicine from Canada to help lower prescription drug costs.
Colorado on Dec. 5 became at least the fourth state to seek federal permission to use the strategy, following Florida, New Hampshire, and New Mexico. President Biden has endorsed the approach, but his administration has yet to greenlight a state plan.
Stall tactics?
Americans pay among the highest prices in the world for brand-name pharmaceuticals. Drugs are generally less expensive in neighboring Canada, where the government controls prices.
Under former President Donald Trump, the U.S. government declared that importing drugs from Canada could be done safely — satisfying a condition spelled out in a 2003 federal drug importation law. The Trump administration finalized rules in September 2020 for states to apply.
During his campaign for the White House, Mr. Biden said he would allow consumers to import prescription drugs from other countries if the federal government certified those drugs as safe.
After Mr. Biden took office in 2021, he ordered the FDA to work with states to import prescription drugs from Canada. In a speech last year about how he was going to reduce drug prices, he cited estimates by Colorado about how much money people in the state could save through importation.
Despite the administration's public show of support, early applicants have been frustrated by the FDA's inaction.
In August, almost two years after submitting its drug proposal, Florida sued the federal government, accusing the Biden administration of slow-walking its review. The federal government denied the accusation. Florida Gov. Ron DeSantis, a potential Republican presidential contender for 2024, has championed the state's effort.
In November, about three months after Florida sued, the FDA sent Florida a 15-page letter asking it to fill dozens of gaps in its plan. The letter asked whether the state wanted to withdraw its application and submit another.
In a December court filing, Florida said "suddenly conjuring so many supposed defects" in its proposal was another "stall tactic" by the government.
New Hampshire Health and Human Services Department spokesperson Jake Leon said New Hampshire's proposal was rejected because it did not identify a Canadian wholesaler that would provide the drugs. He said the FDA told the state it could reapply when it found one.
The Colorado Business Group on Health, which includes large employers, strongly favors importation but realizes the Biden administration is under pressure from groups that profit from the status quo, said Robert Smith, the coalition's executive director. He called concerns about patient safety a "red herring."
"The one thing we know about health care is that it is driven by economic self-interests," he said.
HR3 passed House (12/12/2019) This bill establishes several programs and requirements relating to the prices of prescription drugs, health care coverage and costs, and public health. The bill requires the Department of Health and Human Services (HHS) to negotiate prices for certain drugs.
The Inflation Reduction Act Lowers Health Care Costs Oct 5, 2022 — Through the Inflation Reduction Act, President Biden is delivering on his promise to lower prescription drug costs.
Sweeping Health Measure, Backed by Obama, Passes Senatewww.nytimes.com... › U.S. › Politics
Dec 7, 2016 — The 21st Century Cures Act, already passed by the House, was backed by an unusual alliance of pharmaceutical companies and patients ...
Trump has previously proposed most of the changes made by the executive orders he signed on Friday, but this is the first time they have made it into signed executive orders.
One order would allow for the legal importation of cheaper prescription drugs from countries like Canada, while another would require discounts from drug companies now captured by middlemen to be passed on to patients, Trump said.
Another measure seeks to lower insulin costs while a fourth, which may not be implemented if talks with drug companies are successful, would require Medicare to purchase drugs at the same price that other countries pay, Trump said.
Executives of top drug companies have requested a meeting to discuss how they can lower drug prices, the president said.
“We will see what those discussions indicate but the agency is prepared to move forward,” said Medicare chief Seema Verma.
The orders received swift pushback from the pharmaceutical industry. The move was “a reckless distraction that impedes our ability to respond to the current pandemic – and those we could face in the future,” Pharmaceutical Research and Manufacturers of America said in a statement.
www.reuters.com...
originally posted by: JIMC5499
Do you want to know why we pay more?
It's pretty simple. The UK, Canada and other countries set the prices for drugs. The US doesn't. The drug manufacturers make little profit or take a loss in those countries knowing that they can make it up in the US.
The other issue is the liability in the US. Just look at Oxycodone. Used as prescribed it's fine, yet it is miss-used and the lawsuits fly.